Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Lou

Showing results (331-340 of 346) with videos related to

Pageof 35
Sort By:
Nature Communications|March 31, 2019
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interactionKyle R Simonetta, Joshua Taygerly, Kathleen Boyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2012
RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodentsDaigen Xu, Yong Kim, Jennifer Postelnek, et al.
Military Medical Research|July 2, 2026
A roadmap for medical large language models: a review of foundations, applications, and challengesYu-Yang Sha, Li Yu, Ze-Hui Lin, et al.
Biotechnology Journal|August 11, 2021
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodiesYan Lou, Wenxiang Zhao, Haitao Wei, et al.
Blood|May 17, 2003
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2Ji-Yan Liu, Yu-Quan Wei, Li Yang, et al.
Oncology|August 10, 2005
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activitiesJian-Mei Hou, Ji-Yan Liu, Li Yang, et al.
The Journal of Biological Chemistry|March 26, 2003
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in miceQiu-ming He, Yu-quan Wei, Ling Tian, et al.
Cancer Research|February 5, 2003
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2Jing-Mei Su, Yu-Quan Wei, Ling Tian, et al.
Journal of Medicinal Chemistry|April 10, 2014
Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritisYan Lou, Xiaochun Han, Andreas Kuglstatter, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2016
Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)Yan Lou, Francisco Lopez, Yongying Jiang, et al.
Pageof 35

Showing results (331-340 of 346) with videos related to

Sort By:
Pageof 35
Nature Communications|March 31, 2019
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interactionKyle R Simonetta, Joshua Taygerly, Kathleen Boyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2012
RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodentsDaigen Xu, Yong Kim, Jennifer Postelnek, et al.
Military Medical Research|July 2, 2026
A roadmap for medical large language models: a review of foundations, applications, and challengesYu-Yang Sha, Li Yu, Ze-Hui Lin, et al.
Biotechnology Journal|August 11, 2021
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodiesYan Lou, Wenxiang Zhao, Haitao Wei, et al.
Blood|May 17, 2003
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2Ji-Yan Liu, Yu-Quan Wei, Li Yang, et al.
Oncology|August 10, 2005
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activitiesJian-Mei Hou, Ji-Yan Liu, Li Yang, et al.
The Journal of Biological Chemistry|March 26, 2003
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in miceQiu-ming He, Yu-quan Wei, Ling Tian, et al.
Cancer Research|February 5, 2003
Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2Jing-Mei Su, Yu-Quan Wei, Ling Tian, et al.
Journal of Medicinal Chemistry|April 10, 2014
Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritisYan Lou, Xiaochun Han, Andreas Kuglstatter, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2016
Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK)Yan Lou, Francisco Lopez, Yongying Jiang, et al.
Pageof 35